The store will not work correctly when cookies are disabled.
3-(1-(4-(4-bromophenyl)thiazol-2-yl)-3-methyl-1H-pyrazol-5-yl)-2H-chromen-2-one
ID: ALA4514746
PubChem CID: 129833249
Max Phase: Preclinical
Molecular Formula: C22H14BrN3O2S
Molecular Weight: 464.34
Molecule Type: Unknown
Associated Items:
Names and Identifiers
Canonical SMILES: Cc1cc(-c2cc3ccccc3oc2=O)n(-c2nc(-c3ccc(Br)cc3)cs2)n1
Standard InChI: InChI=1S/C22H14BrN3O2S/c1-13-10-19(17-11-15-4-2-3-5-20(15)28-21(17)27)26(25-13)22-24-18(12-29-22)14-6-8-16(23)9-7-14/h2-12H,1H3
Standard InChI Key: BCXBNLSKBFXXDY-UHFFFAOYSA-N
Molfile:
RDKit 2D
29 33 0 0 0 0 0 0 0 0999 V2000
2.5583 -24.1135 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.5571 -24.9330 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.2652 -25.3420 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.2634 -23.7046 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.9720 -24.1099 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.9754 -24.9351 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.6877 -25.3425 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
5.4013 -24.9292 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.3979 -24.1040 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.6810 -23.6921 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.1101 -25.3359 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
6.1096 -23.6920 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.8572 -24.0221 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.4021 -23.4131 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.9913 -22.7066 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
6.1925 -22.8791 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
5.5862 -22.3338 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.6690 -21.5208 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
4.9214 -21.1908 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.3765 -21.7999 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.7874 -22.5062 0.0000 S 0 0 0 0 0 0 0 0 0 0 0 0
8.2173 -23.4096 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.9155 -20.3720 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.6240 -19.9593 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.6185 -19.1413 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.9059 -18.7362 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.1974 -19.1551 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.2064 -19.9718 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.8989 -17.9190 0.0000 Br 0 0 0 0 0 0 0 0 0 0 0 0
1 2 2 0
2 3 1 0
3 6 2 0
5 4 2 0
4 1 1 0
5 6 1 0
5 10 1 0
6 7 1 0
7 8 1 0
8 9 1 0
9 10 2 0
8 11 2 0
12 13 2 0
13 14 1 0
14 15 2 0
15 16 1 0
16 12 1 0
9 12 1 0
17 18 2 0
18 19 1 0
19 20 2 0
20 21 1 0
21 17 1 0
16 17 1 0
14 22 1 0
19 23 1 0
23 24 2 0
24 25 1 0
25 26 2 0
26 27 1 0
27 28 2 0
28 23 1 0
26 29 1 0
M END
Associated Targets(Human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Unknown | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 464.34 | Molecular Weight (Monoisotopic): 462.9990 | AlogP: 5.84 | #Rotatable Bonds: 3 |
Polar Surface Area: 60.92 | Molecular Species: NEUTRAL | HBA: 6 | HBD: ┄ |
#RO5 Violations: 1 | HBA (Lipinski): 5 | HBD (Lipinski): ┄ | #RO5 Violations (Lipinski): 1 |
CX Acidic pKa: ┄ | CX Basic pKa: 1.44 | CX LogP: 5.73 | CX LogD: 5.73 |
Aromatic Rings: 5 | Heavy Atoms: 29 | QED Weighted: 0.31 | Np Likeness Score: -1.48 |